Could a Cincinnati bank merger create more jobs?
UC economics professor weighs in on Fifth Third’s bid to buy Comerica
WLWT reported that Fifth Third Bank plans to acquire Comerica, a Dallas-based regional bank, in a $10.9 billion deal.
Pending regulatory approval, it would make Fifth Third the ninth largest bank in the country.
David Brasington, economics professor at the University of Cincinnati's Carl H. Lindner College of Business, spoke to WLWT on what the potential merger could mean for the queen city.
"My initial impression is that it's great for the city because Fifth Third is a thriving institution and this will probably just make it stronger," he told WLWT.
Brasington explained that Fifth Third’s acquisition could lead to more regulatory stress tests, and in turn, more work. He said it could create more jobs in the city and draw in more people, including college students.
"To be able to have a big institution in the city that's gaining jobs instead of losing jobs would be really attractive for college students," Brasington said.
Featured image at top of $100 bills. Photo/Adobe Stock
Related Stories
UC professor curates Little Women exhibition to accompany Playhouse in the Park production
February 16, 2026
The exhibition traces how artists shaped the visual legacy of Alcott’s beloved novel.
Can Cincinnati become a Blue Zone?
February 12, 2026
Under the Blue Zones Project umbrella, 75 U.S. cities currently are working on group diet and exercise programs while also changing the community’s culture, so that residents are encouraged to make healthy choices. Cincinnati is not an official Blue Zones Project city yet, but Florence Rothenberg, MD, adjunct professor of cardiology at the University of Cincinnati College of Medicine and clinical cardiologist at the Cincinnati VA Medical Center, is leading one public effort to encourage a Blue Zone lifestyle. Her work was recently featured in Cincinnati Magazine.
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
February 12, 2026
MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.